And That's a Wrap: HealthInvest 2024

We're still buzzing from the energy and excitement of our inaugural HealthInvest summit in partnership with Morgans and Stockhead, which took place on September 18 at Kittyhawk. This Sydney event exceeded expectations, featuring presentations from five leading and emerging life sciences companies and sparking valuable connections among investors, industry experts, and thought leaders.

Full House

HealthInvest definitely met our expectations, with a packed house of engaged attendees. Our presenting companies shared inspiring presentations, followed by some insightful Q&A, overseen by Morgan’s senior analyst, Scott Power. Our presenters included:

• Imricor Medical Systems (ASX: IMR) - Nick Corkill, Vice President Corporate Strategy
• Impedimed (ASX: IPD) - Dr Parmjot Bains, Managing Director & CEO
• Race Oncology (ASX: RAC) - Dr Peter Smith, Executive Chair
• Percheron Therapeutics (ASX: PER) - Dr James Garner, Managing Director & CEO
• Clarity Pharmaceuticals (ASX: CU6) - Dr Alan Taylor, Executive Chair

The event offered a platform for investors to hear from five of the ASX’s most innovative life sciences companies, while also offering networking opportunities, sparking valuable connections and conversations.

Company Presentations

View a copy of the presentations here.

Media coverage and presenter videos

Our media partner, Stockhead released an event summary, accompanied by video interviews with each presenter. You can access the article to read and watch the content here.

See below for some highlights of the evening:

A Big Thank You!

We're grateful to our presenting companies for sharing their vision, to our partners, Morgans and Stockhead for their support and all our attendees for their enthusiasm and engagement. Until next time!